Profil
Giovanni Selvaggi currently works at Xcovery Holding, Inc., as Chief Executive Officer & Medical Officer from 2021 and CEL-SCI Corp., as Chief Medical Officer from 2024.
Dr. Selvaggi also formerly worked at Imugene Ltd., as Chief Medical Officer from 2022 to 2023 and Oncolytics Biotech (US), Inc., as Vice President-Clinical Development.
Dr. Selvaggi received his graduate degree from the University of Torino School of Medicine.
Postes actifs de Giovanni Selvaggi
| Sociétés | Poste | Début |
|---|---|---|
| CEL-SCI CORPORATION | Directeur Technique/Scientifique/R&D | 01/05/2024 |
Xcovery Holding, Inc.
Xcovery Holding, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology focused bio-pharmaceutical company | Directeur Général | 01/03/2021 |
Anciens postes connus de Giovanni Selvaggi
| Sociétés | Poste | Fin |
|---|---|---|
| IMUGENE LIMITED | Directeur Technique/Scientifique/R&D | 18/07/2023 |
Oncolytics Biotech (US), Inc.
Oncolytics Biotech (US), Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CEL-SCI Corp.
CEL-SCI Corp. BiotechnologyHealth Technology Provides immunotherapy products for the treatment of cancer and infectious diseases | Health Technology |
Xcovery Holding, Inc.
Xcovery Holding, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology focused bio-pharmaceutical company | Health Technology |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Oncolytics Biotech (US), Inc.
Oncolytics Biotech (US), Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















